Skip to main content
Erschienen in: Medical Molecular Morphology 2/2014

01.06.2014 | Original Paper

Diamine oxidase as a marker of intestinal mucosal injury and the effect of soluble dietary fiber on gastrointestinal tract toxicity after intravenous 5-fluorouracil treatment in rats

verfasst von: Ian Fukudome, Michiya Kobayashi, Ken Dabanaka, Hiromichi Maeda, Ken Okamoto, Takehiro Okabayashi, Ryoko Baba, Nana Kumagai, Koji Oba, Mamoru Fujita, Kazuhiro Hanazaki

Erschienen in: Medical Molecular Morphology | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

The level of plasma diamine oxidase (DAO) activity is associated with the maturation and integrity of small intestinal mucosa. This study in rats investigated whether a decreased level of plasma DAO could reflect the severity of mucosal injury due to intravenous 5-fluorouracil (5-FU) treatment. The beneficial effect of soluble dietary fiber (SDF) on preventing diarrhea after 5-FU treatment was also examined. To induce diarrhea, 5-FU (50 mg/kg/day for four days) was administered via the tail vein with or without SDF supplementation. After 5-FU treatment, the majority of rats developed moderate to severe diarrhea, and levels of plasma DAO activity significantly decreased compared to those of control group (P < 0.05). Scanning electron microscopy revealed disarrangement of the small intestinal villi. Contrarily, the rats supplemented with SDF had diarrhea less frequently (50.0 vs. 91.7 %, P = 0.025) on day five, and DAO activity levels were significantly higher than in those rats administered 5-FU alone (8.25 ± 5.34 vs. 5.50 ± 4.32, P = 0.023). In conclusion, plasma DAO activity decreases in response to severe intestinal mucosal injury after 5-FU treatment, and SDF supplementation might be a practical and useful treatment for reducing the intestinal toxicity of 5-FU.
Literatur
1.
Zurück zum Zitat Kusche J, Lorenz W, Schmidt J (1975) Oxidative deamination of biogenic amines by intestinal amine oxidases: histamine is specially inactivated by diamine oxidase. Hoppe-Seyler’s Z Physiol Chem 356:1485–1496PubMedCrossRef Kusche J, Lorenz W, Schmidt J (1975) Oxidative deamination of biogenic amines by intestinal amine oxidases: histamine is specially inactivated by diamine oxidase. Hoppe-Seyler’s Z Physiol Chem 356:1485–1496PubMedCrossRef
2.
Zurück zum Zitat Jänne J, Pösö H, Raina A (1978) Polyamines in rapid growth and cancer. Biochim Biophys Acta 473:241–293PubMed Jänne J, Pösö H, Raina A (1978) Polyamines in rapid growth and cancer. Biochim Biophys Acta 473:241–293PubMed
3.
Zurück zum Zitat Baylin SB, Stevens SA, Shakir KM (1978) Association of diamine oxidase and ornithine with maturing cells in rapidly proliferating epithelium. Biochim Biophys Acta 541:415–419PubMedCrossRef Baylin SB, Stevens SA, Shakir KM (1978) Association of diamine oxidase and ornithine with maturing cells in rapidly proliferating epithelium. Biochim Biophys Acta 541:415–419PubMedCrossRef
4.
Zurück zum Zitat Maintz L, Novak N (2007) Histamine and histamine intolerance. Am J Clin Nutr 85:1185–1196PubMed Maintz L, Novak N (2007) Histamine and histamine intolerance. Am J Clin Nutr 85:1185–1196PubMed
5.
Zurück zum Zitat D’Agostino L, Ciacci C, Capuano G, Daniele B, D’Agostino G, Barone MV, Rodino S, Budillon G, Mazzacca G (1986) Metabolic fate of plasma diamine oxidase: evidence of isolated and perfused rat liver uptake. Digestion 34:243–250PubMedCrossRef D’Agostino L, Ciacci C, Capuano G, Daniele B, D’Agostino G, Barone MV, Rodino S, Budillon G, Mazzacca G (1986) Metabolic fate of plasma diamine oxidase: evidence of isolated and perfused rat liver uptake. Digestion 34:243–250PubMedCrossRef
6.
Zurück zum Zitat Shakir KM, Margolis S, Baylin SB (1977) Localization of histaminase (diamine oxidase) in rat small intestinal mucosa; site of release by heparin. Biochem Pharmacol 26:2343–2347PubMedCrossRef Shakir KM, Margolis S, Baylin SB (1977) Localization of histaminase (diamine oxidase) in rat small intestinal mucosa; site of release by heparin. Biochem Pharmacol 26:2343–2347PubMedCrossRef
7.
Zurück zum Zitat Bieganski T (1983) Biochemical, physiological and pathophysiological aspects of intestinal diamine oxidase. Acta Physiol Pol 34:139–154PubMed Bieganski T (1983) Biochemical, physiological and pathophysiological aspects of intestinal diamine oxidase. Acta Physiol Pol 34:139–154PubMed
8.
Zurück zum Zitat Luk GD, Bayless TM, Baylin SB (1980) Diamine oxidase (DAO) a circulating marker for rat mucosal maturation and integrity. J Clin Invest 66:66–70PubMedCentralPubMedCrossRef Luk GD, Bayless TM, Baylin SB (1980) Diamine oxidase (DAO) a circulating marker for rat mucosal maturation and integrity. J Clin Invest 66:66–70PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Nakao M, Ogura Y, Satake S, Ito I, Iguchi A, Takagi K, Nabeshima T (2002) Usefulness of soluble dietary fiber for the treatment of diarrhea during enteral nutrition in elderly patients. Nutrition 18:35–39PubMedCrossRef Nakao M, Ogura Y, Satake S, Ito I, Iguchi A, Takagi K, Nabeshima T (2002) Usefulness of soluble dietary fiber for the treatment of diarrhea during enteral nutrition in elderly patients. Nutrition 18:35–39PubMedCrossRef
10.
Zurück zum Zitat Anderson JW, Baird P, Davis RH Jr, Ferreri S, Knudtson M, Koraym A, Waters V, Williams CL (2009) Health benefits of dietary fiber. Nutr Rev 67:188–205PubMedCrossRef Anderson JW, Baird P, Davis RH Jr, Ferreri S, Knudtson M, Koraym A, Waters V, Williams CL (2009) Health benefits of dietary fiber. Nutr Rev 67:188–205PubMedCrossRef
11.
Zurück zum Zitat Dranitsaris G, Shah A, Spirovski B, Vincent M (2007) Severe diarrhea in patients with advanced-stage colorectal cancer receiving FOLFOX or FOLFIRI chemotherapy: the development of a risk prediction tool. Clin Colorectal Cancer 6:367–373PubMedCrossRef Dranitsaris G, Shah A, Spirovski B, Vincent M (2007) Severe diarrhea in patients with advanced-stage colorectal cancer receiving FOLFOX or FOLFIRI chemotherapy: the development of a risk prediction tool. Clin Colorectal Cancer 6:367–373PubMedCrossRef
12.
Zurück zum Zitat Stein A, Voigt W, Jordan K (2010) Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management. Ther Adv Med Oncol 2:51–63PubMedCentralPubMedCrossRef Stein A, Voigt W, Jordan K (2010) Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management. Ther Adv Med Oncol 2:51–63PubMedCentralPubMedCrossRef
13.
Zurück zum Zitat Moriyama K, Kouchi Y, Morinaga H, Irimura K, Hayashi T, Ohuchida A, Goto T, Yoshizawa Y (2006) Diamine oxidase, a plasma biomarker in rats to GI tract toxicity of oral fluorouracil anti-cancer drugs. Toxicology 217:233–239PubMedCrossRef Moriyama K, Kouchi Y, Morinaga H, Irimura K, Hayashi T, Ohuchida A, Goto T, Yoshizawa Y (2006) Diamine oxidase, a plasma biomarker in rats to GI tract toxicity of oral fluorouracil anti-cancer drugs. Toxicology 217:233–239PubMedCrossRef
14.
Zurück zum Zitat Siber GR, Mayer RJ, Levin MJ (1980) Increased gastrointestinal absorption of large molecules in patients after 5-fluorouracil therapy for metastatic colon carcinoma. Cancer Res 40:3430–3436PubMed Siber GR, Mayer RJ, Levin MJ (1980) Increased gastrointestinal absorption of large molecules in patients after 5-fluorouracil therapy for metastatic colon carcinoma. Cancer Res 40:3430–3436PubMed
15.
Zurück zum Zitat Kusche J, Mennigen R, Erpenbach K (1988) The intestinal diamine oxidase activity under the influence of adaptive proliferation of intestinal mucosa—a proliferation terminating principle? Agents Actions 23:354–356PubMedCrossRef Kusche J, Mennigen R, Erpenbach K (1988) The intestinal diamine oxidase activity under the influence of adaptive proliferation of intestinal mucosa—a proliferation terminating principle? Agents Actions 23:354–356PubMedCrossRef
16.
Zurück zum Zitat Fukunaga T, Sasaki M, Araki Y, Okamoto T, Yasuoka T, Tsujikawa T, Fujiyama Y, Bamba T (2003) Effects of the soluble fibre pectin on intestinal cell proliferation, fecal short chain fatty acid production and microbial population. Digestion 67:42–49PubMedCrossRef Fukunaga T, Sasaki M, Araki Y, Okamoto T, Yasuoka T, Tsujikawa T, Fujiyama Y, Bamba T (2003) Effects of the soluble fibre pectin on intestinal cell proliferation, fecal short chain fatty acid production and microbial population. Digestion 67:42–49PubMedCrossRef
17.
Zurück zum Zitat Tappenden KA, Albin DM, Bartholome AL, Mangian HF (2003) Glucagon-like peptide-2 and short-chain fatty acids: a new twist to an old story. J Nutr 133:3717–3720PubMed Tappenden KA, Albin DM, Bartholome AL, Mangian HF (2003) Glucagon-like peptide-2 and short-chain fatty acids: a new twist to an old story. J Nutr 133:3717–3720PubMed
18.
Zurück zum Zitat Gee JM, Lee-Finglas W, Wortley GW, Johnson IT (1996) Fermentable carbohydrates elevate plasma enteroglucagon but high viscosity is also necessary to stimulate small bowel mucosal cell proliferation in rats. J Nutr 126:373–379PubMed Gee JM, Lee-Finglas W, Wortley GW, Johnson IT (1996) Fermentable carbohydrates elevate plasma enteroglucagon but high viscosity is also necessary to stimulate small bowel mucosal cell proliferation in rats. J Nutr 126:373–379PubMed
Metadaten
Titel
Diamine oxidase as a marker of intestinal mucosal injury and the effect of soluble dietary fiber on gastrointestinal tract toxicity after intravenous 5-fluorouracil treatment in rats
verfasst von
Ian Fukudome
Michiya Kobayashi
Ken Dabanaka
Hiromichi Maeda
Ken Okamoto
Takehiro Okabayashi
Ryoko Baba
Nana Kumagai
Koji Oba
Mamoru Fujita
Kazuhiro Hanazaki
Publikationsdatum
01.06.2014
Verlag
Springer Japan
Erschienen in
Medical Molecular Morphology / Ausgabe 2/2014
Print ISSN: 1860-1480
Elektronische ISSN: 1860-1499
DOI
https://doi.org/10.1007/s00795-013-0055-7

Weitere Artikel der Ausgabe 2/2014

Medical Molecular Morphology 2/2014 Zur Ausgabe

Neu im Fachgebiet Pathologie

Open Access 15.04.2024 | Biomarker | Schwerpunkt: Next Generation Pathology

Molekularpathologische Untersuchungen im Wandel der Zeit

11.04.2024 | Pathologie | Schwerpunkt: Next Generation Pathology

Vergleichende Pathologie in der onkologischen Forschung

Open Access 08.04.2024 | GIST | CME

Gastrointestinale Stromatumoren

Wo stehen wir?

03.04.2024 | Zielgerichtete Therapie | Schwerpunkt: Next Generation Pathology

Personalisierte Medizin in der Onkologie